Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Bvf Inc/Il
Form 13F · Q2 2026

Bvf Inc/Il

CIK 1056807申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$39.1亿
申报组合市值
44
持仓数量
12
Quarters on record
Top 50
持仓数量

Bvf Inc/Il——持仓

共 44 个持仓中的前 44 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1RVMD Revolution Medicines Inc3.0M+3.8%$5.6亿14.2%
2KYMR Kymera Therapeutics Inc3.9M−29.6%$4.4亿11.4%
3XOMA ROYALTY CORPORATION Xoma Royalty Corporation7.6M+193.1%$3.2亿8.3%
4MLTX Moonlake Immunotherapeutics16.0M+0.0%$3.1亿8.0%
5GHRS Gh Research Plc8.7M+0.0%$2.3亿5.9%
6GPCR Structure Therapeutics Inc3.4M−2.7%$1.8亿4.6%
7NKTR Nektar Therapeutics2.4M−6.6%$1.7亿4.3%
8MIRM Mirum Pharmaceuticals Inc1.1M−33.4%$1.2亿3.2%
9XNCR Xencor Inc7.1M+0.0%$1.1亿2.9%
10ALKS Alkermes Plc2.2M+7.7%$1.1亿2.9%
11GLUE Monte Rosa Therapeutics Inc4.5M+0.0%$1.1亿2.8%
12CGEM Cullinan Therapeutics Inc5.8M+0.0%$1.0亿2.7%
13PVLA Palvella Therapeutics Inc Ne672,789−30.0%$1.0亿2.6%
14ZYME Zymeworks Inc3.6M−2.3%$9539万2.4%
15KURA Kura Oncology Inc8.4M+0.0%$9265万2.4%
16IRON Disc Medicine Inc1.2M−9.3%$8438万2.2%
17STOK Stoke Therapeutics Inc2.5M+0.0%$8336万2.1%
18OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc5.3M+0.0%$6625万1.7%
19ANNX Annexon Inc8.7M+0.0%$4967万1.3%
20CBIO Crescent Biopharma Inc.2.7M+0.0%$4948万1.3%
21ACIU Ac Immune Sa19.8M+0.0%$4718万1.2%
22TYRA Tyra Biosciences Inc1.5M−25.3%$4715万1.2%
23STRO Sutro Biopharma Inc1.3M+0.0%$4156万1.1%
24IMCR Immunocore Hldgs Plc1.3M+0.0%$4110万1.1%
25AVTX Avalo Therapeutics Inc2.1M+27.1%$3836万1.0%
26FDMT 4D Molecular Therapeutics In2.9M+0.0%$3829万1.0%
27QTTB Q32 Bio Inc2.4M—$2994万0.8%
28AVR Anteris Technologies Global3.0M+0.0%$2955万0.8%
29FHTX Foghorn Therapeutics Inc5.8M+0.0%$2851万0.7%
30ABSI Absci Corporation2.4M—$2737万0.7%
31ELDN Eledon Pharmaceuticals Inc6.3M+0.0%$2480万0.6%
32IVVD Invivyd Inc28.2M+44.3%$2457万0.6%
33SGMT Sagimet Biosciences Inc2.5M—$1932万0.5%
34OKUR Onkure Therapeutics Inc3.2M+63.5%$1476万0.4%
35IMUX Immunic Inc765,295—$1176万0.3%
36XFOR X4 Pharmaceuticals Inc2.2M+0.0%$1043万0.3%
37IMA Imagenebio Inc1.1M+0.0%$655万0.2%
38TCRX Tscan Therapeutics Inc5.6M+0.0%$545万0.1%
39RACC Research Alliance Corp Iii500,000—$535万0.1%
40MOLN Molecular Partners Ag1.4M+0.0%$515万0.1%
41TENX Tenax Therapeutics Inc339,549+0.0%$494万0.1%
42ENTX Entera Bio Ltd2.4M—$429万0.1%
43IVA Inventiva Sa686,040+0.0%$259万0.1%
44ENGN Engene Therapeutics Inc945,402—$27万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。